Yap SM, Perry L, Ridout D, Baranello G, Manzur A, Main M, Muntoni F, Sarkozy A. Retrospective deep phenotypic and genotypic analysis of UK patients with recessive early onset titinopathy. Abstracts of the 17th UK Neuromuscular Translational Research Conference, 17th and 18th April 2024. J Neuromuscul Dis. 2024;11(s1):S1–S73. doi:10.3233/JND-249001. Conference Abstract.

Yap SM, Davenport L, Cogley C, Craddock F, Kennedy A, Gaughan M, Kearney H, Tubridy N, De Looze C, O'Keeffe F, Reilly RB, McGuigan C. Word finding, prosody and social cognition in multiple sclerosis. J Neuropsychol. 2023;17(1):32–62. doi:10.1111/jnp.12285. Journal Article.

Mahady L, White J, Rafee S, Yap SM, O'Riordan S, Hutchinson M, Gough P, O'Keeffe F. Social cognition in cervical dystonia. Clin Park Relat Disord. 2023;9:100217. doi:10.1016/j.prdoa.2023.100217. Journal Article.

Davenport L, Cogley C, Monaghan R, Gaughan M, Yap M, Bramham J, Tubridy N, McGuigan C, O'Keeffe F. Investigating the association of mood and fatigue with objective and subjective cognitive impairment in multiple sclerosis. J Neuropsychol. 2022;16(3):537–554. doi:10.1111/jnp.12283. Journal Article.

Bellew D, Davenport L, Monaghan R, Cogley C, Gaughan M, Yap SM, Tubridy N, Bramham J, McGuigan C, O'Keeffe F. Interpreting the clinical importance of the relationship between subjective fatigue and cognitive impairment in multiple sclerosis (MS): How BICAMS performance is affected by MS-related fatigue. Mult Scler Relat Disord. 2022;67:104161. doi:10.1016/j.msard.2022.104161. Journal Article.

O'Keeffe C, Yap SM, Davenport L, Cogley C, Craddock F, Kennedy A, Tubridy N, Looze C, Suleyman N, O'Keeffe F, Reilly RB, McGuigan C. Association between speech rate measures and cognitive function in people with relapsing and progressive multiple sclerosis. Mult Scler J Exp Transl Clin. 2022;8(3):20552173221119813. doi:10.1177/13524585221119813. Journal Article.

Gaughan M, Gilligan M, Patterson I, McGurgan I, Yap SM, Tubridy N, McGuigan C. Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosis. Mult Scler Relat Disord. 2022;68:104251. doi:10.1016/j.msard.2022.104251. Journal Article.

Yap SM, Etzelmueller MS, O'Keeffe C, Gaughan M, Kearney H, Tubridy N, Reilly RB, McGuigan C. Postural stability provides additional clinical value as a disability metric compared with brain atrophy in progressive multiple sclerosis. ECTRIMS 2021 ePoster Abstracts. Mult Scler. 2021;27(2_suppl):PP.134–740. Conference Abstract.

Yap SM, Al Hinai M, Gaughan M, Callanan I, Kearney H, Tubridy N, McGuigan C. Vaccine hesitancy among people with multiple sclerosis. ECTRIMS 2021 ePoster Abstracts. Mult Scler. 2021;27(2_suppl):PP.134–740. Conference Abstract.

Yap SM, Etzelmueller MS, O'Keeffe C, Gaughan M, Kearney H, Tubridy N, Reilly RB, McGuigan C. Static posturography measures enhance the clinical validity of the multiple sclerosis functional composite as a disability marker for progressive multiple sclerosis. Neurology. 2021;96(15 Supplement):1505. Conference Abstract.

Yap SM, Etzelmueller MS, O'Keeffe C, Gaughan M, Kearney H, Tubridy N, Reilly RB, McGuigan C. Postural facilitation can occur during dual-task performance in people with progressive multiple sclerosis and is related to upper extremity function. Neurology. 2021;96(15 Supplement):2539. Conference Abstract.

Gaughan M, Monaghan R, O'Connell K, McNicholas N, Yap SM, Tubridy N, O'Keeffe F, McGuigan C. Five-year follow up of the original Irish BICAMS validation cohort. Mult Scler Relat Disord. 2021;56:103257. doi:10.1016/j.msard.2021.103257. Journal Article.

Yap SM, Etzelmueller MS, O'Keeffe C, Gaughan M, Kearney H, Tubridy N, Reilly RB, McGuigan C. Postural stability is a valid and meaningful disability metric in progressive MS with potential for use in neuroprotective therapy trials. Mult Scler Relat Disord. 2021;52:102946. doi:10.1016/j.msard.2021.102946. Journal Article.

Yap SM, Al Hinai M, Gaughan M, Callanan I, Kearney H, Tubridy N, McGuigan C. Vaccine hesitancy among people with multiple sclerosis. Mult Scler Relat Disord. 2021;56:103236. doi:10.1016/j.msard.2021.103236. Journal Article.

Yap SM, Etzelmueller MS, O'Keeffe C, Gaughan M, Reilly RB, McGuigan C. P0134 Preliminary validation of static posturography as a disability outcome measure in progressive multiple sclerosis. MSVirtual 2020 – Poster Abstracts. Mult Scler. 2020;26(3_suppl):118–659. doi:10.1177/1352458520974937. Conference Abstract.

Yap SM, Dillon M, Crowley RK, McGuigan C. Clinical Manifestation of Alemtuzumab-induced Autoimmune Thyroid Disease in People with Highly Active Multiple Sclerosis Is Dependent on Age and Presence of Early Brainstem Involvement (1292). Neurology. 2020;94(15 Supplement):1292. Conference Abstract.

Yap SM, Dillon M, Crowley RK, McGuigan C. Alemtuzumab-related thyroid disease in people with multiple sclerosis is associated with age and brainstem phenotype at disease onset. Mult Scler J Exp Transl Clin. 2020;6(2):2055217320933928. doi:10.1177/2055217320933928. Journal Article.

Yap SM, Saeed M, Logan P, Healy DG. Bartonella neuroretinitis (cat-scratch disease). Pract Neurol. 2020;20(6):505–506. doi:10.1136/practneurol-2020-002586. Journal Article.

Yap SM, Smyth S. Ryanodine receptor 2 (RYR2) mutation: A potentially novel neurocardiac calcium channelopathy manifesting as primary generalised epilepsy. Seizure. 2019;67:11–14. doi:10.1016/j.seizure.2019.02.017. Journal Article.

McNicholas N, Lockhart A, Yap SM, O'Connell K, Tubridy N, Hutchinson M, McGuigan C. New versus old: Implications of evolving diagnostic criteria for relapsing-remitting multiple sclerosis. Mult Scler. 2019;25(6):867–870. doi:10.1177/1352458518770088. Journal Article.

Yap SM, McNicholas N, Hutchinson M, McGuigan C. Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis – not always self-limiting, fully reversible, or predictable. Mult Scler. 2018;24(4):552–553. doi:10.1177/1352458517719151. Journal Article.

McNicholas N, O'Connell K, Yap SM, Killeen RP, Hutchinson M, McGuigan C. Cognitive dysfunction in early multiple sclerosis: a review. QJM. 2018;111(6):359–364. doi:10.1093/qjmed/hcx070. Journal Article.

Yap SM, Iyer P, Smyth S. Reflex Tongue Protrusion as a Novel Release Phenomenon in Dementia in Adulthood. Mov Disord Clin Pract. 2018;5(6):661–662. doi:10.1002/mdc3.12675. Journal Article.

Yap SM, McNicholas N, Jordan S, Buckley L, Iyer P, Shaikh E, Tubridy N, Hutchinson M, McGuigan C. A prospective study of fracture risk, fall risk and serum vitamin D levels in ambulatory patients with moderately advanced multiple sclerosis. ECTRIMS Online Library. 2017;199457; EP1437. Conference Abstract.

Yap SM, McNicholas N, O'Riordan S, Fitzgerald J, Watson A, McGuigan C. Alemtuzumab-associated anti-glomerular basement membrane antibody-positive glomerulonephritis complicated by secondary thrombotic microangiopathy and posterior reversible encephalopathy syndrome. ECTRIMS Online Library. 2017;199760; EP1740. Conference Abstract.

Yap SM, McNicholas N, Tubridy N, Hutchinson M, McGuigan C. A potential role for continuation of natalizumab therapy in patients with secondary progressive multiple sclerosis. Neurology. 2017;88(16 Supplement):P5.358. Conference Abstract.

Yap SM, O'Donnell L, Togher Z, Dillon M, McNicholas N, Tubridy N, Hutchinson M, McGuigan C. Safety monitoring of alemtuzumab therapy in active relapsing multiple sclerosis: necessary, manageable but resource-intensive. Neurology. 2017;88(16 Suppl):P5.401. Conference Abstract.

Yap SM, Murray B, Lynch T, Kavanagh E, MacMahon P. A role for susceptibility weighted imaging in progressive multifocal leukoencephalopathy. Ir Med J. 2017;110(4):549. Journal Article.

Yap SM, McGuigan C. High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - YES. Mult Scler. 2017;23(6):765–767. doi:10.1177/1352458517697909. Journal Article.

Yap SM, MacEneaney P, Ryan C, O'Toole O. Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia. BMJ Case Rep. 2016;2016:bcr2016214677. doi:10.1136/bcr-2016-214677. Journal Article.

Yap SM, McNamara B. Foot Drop: Looking Beyond Common Peroneal Nerve Palsy: A Neurophysiology Centre Experience. Ir Med J. 2016;109(4):388. Journal Article.

Yap SM, Farrell M, Cryan J, Smyth S. An Irish case of limb-girdle muscular dystrophy 2I with structural eye involvement. Muscle Nerve. 2016;54(3):509–510. doi:10.1002/mus.25059. Journal Article.

Yap SM, Wyse G, Higgins JN, O'Brien E, Cronin S. Auditory hallucination in basilar occlusion: I heard it was the basilar. Pract Neurol. 2016;16(2):142–145. doi:10.1136/practneurol-2015-001189. Journal Article.

Yap SM, Lynch T, MacMahon P, Murray B. Paraneoplastic Atypical Parkinsonism with Anti-CRMP5 Antibodies and Severe Caudate and Putaminal Hypometabolism on 18-Fluorodeoxyglucose Positron Emission Tomography of the Brain. Mov Disord Clin Pract. 2016;4(2):263–265. doi:10.1002/mdc3.12370. Journal Article.

Yap SM, Dablouk MO, O'Sullivan S. A comparison of standards of care in Parkinson's disease between a general neurology clinic and a specialist movement disorders clinic based on the UK NICE guidelines. Mov Disord. 2016;31(Suppl 2). Abstract 1787. Conference Abstract.